Pamelor Articles
Novartis sells off old CNS drugs in USA
25 June 2001
Teva Receives Approval
17 April 1995
SUSTAINABLE EARNINGS GROWTH FOR SANDOZ
16 August 1993
HHS RECOMMENDATIONS FOR ANTIDEPRESSANTS
3 May 1993
NEUROPHARMACEUTICAL MARKET IN USA
19 April 1993
WORLD CNS MARKET IS LARGE AND FRAGMENTED
22 February 1993
SANDOZ 1992 SALES SEE 8% INCREASE
1 February 1993
FDA APPROVES 26 NEWDRUGS IN 1992
25 January 1993
Showing 1-9 of 9 articles
- 1
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
